Nadim J Shah
Overview
Explore the profile of Nadim J Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
2380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lohmann P, Elahmadawy M, Gutsche R, Werner J, Bauer E, Ceccon G, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33353180
Currently, a reliable diagnostic test for differentiating pseudoprogression from early tumor progression is lacking. We explored the potential of O-(2-[F]fluoroethyl)-L-tyrosine (FET) positron emission tomography (PET) radiomics for this clinically important...
12.
Ceccon G, Lohmann P, Werner J, Tscherpel C, Dunkl V, Stoffels G, et al.
J Nucl Med
. 2020 Nov;
62(7):918-925.
PMID: 33158907
The goal of this study was to compare the value of contrast-enhanced MRI and O-(2-[F]fluoroethyl)-l-tyrosine (F-FET) PET for response assessment in glioma patients after adjuvant temozolomide chemotherapy (TMZ). After biopsy...
13.
Kullmann S, Abbas Z, Machann J, Shah N, Scheffler K, Birkenfeld A, et al.
J Neuroendocrinol
. 2020 Oct;
32(12):e12907.
PMID: 33025697
There is growing evidence that obesity is associated with inflammation in the brain, which could contribute to the pathogenesis of obesity. In humans, it is challenging to detect brain inflammation...
14.
Kocher M, Jockwitz C, Caspers S, Schreiber J, Farrher E, Stoffels G, et al.
Neuroimage Clin
. 2020 Jun;
27:102287.
PMID: 32540630
Background: Progressive cognitive decline following multimodal neurooncological treatment is a common observation in patients suffering from malignant glioma. Alterations of the default-mode network (DMN) represent a possible source of impaired...
15.
Bauer E, Stoffels G, Blau T, Reifenberger G, Felsberg J, Werner J, et al.
Eur J Nucl Med Mol Imaging
. 2020 Feb;
47(6):1486-1495.
PMID: 32034446
Purpose: Integrated histomolecular diagnostics of gliomas according to the World Health Organization (WHO) classification of 2016 has refined diagnostic accuracy and prediction of prognosis. This study aimed at exploring the...
16.
Werner J, Stoffels G, Lichtenstein T, Borggrefe J, Lohmann P, Ceccon G, et al.
Eur J Nucl Med Mol Imaging
. 2019 Jun;
46(9):1889-1901.
PMID: 31203420
Background: Following brain cancer treatment, the capacity of anatomical MRI to differentiate neoplastic tissue from treatment-related changes (e.g., pseudoprogression) is limited. This study compared apparent diffusion coefficients (ADC) obtained by...
17.
Rosenberg J, Lechea N, Pentang G, Shah N
Front Neuroendocrinol
. 2018 Nov;
52:79-112.
PMID: 30392901
Due to its increasing prevalence, Type 2 diabetes mellitus (T2DM) represents a major health challenge for modern society. Despite it being of fundamental interest, only a few MRI studies have...
18.
Lohmann P, Stavrinou P, Lipke K, Bauer E, Ceccon G, Werner J, et al.
Eur J Nucl Med Mol Imaging
. 2018 Oct;
46(3):591-602.
PMID: 30327856
Purpose: Areas of contrast enhancement (CE) on MRI are usually the target for resection or radiotherapy target volume definition in glioblastomas. However, the solid tumour mass may extend beyond areas...
19.
Lohmann P, Lerche C, Bauer E, Steger J, Stoffels G, Blau T, et al.
Sci Rep
. 2018 Sep;
8(1):13328.
PMID: 30190592
Mutations in the isocitrate dehydrogenase (IDH mut) gene have gained paramount importance for the prognosis of glioma patients. To date, reliable techniques for a preoperative evaluation of IDH genotype remain...
20.
Lohmann P, Kocher M, Ceccon G, Bauer E, Stoffels G, Viswanathan S, et al.
Neuroimage Clin
. 2018 Sep;
20:537-542.
PMID: 30175040
Background: The aim of this study was to investigate the potential of combined textural feature analysis of contrast-enhanced MRI (CE-MRI) and static O-(2-[F]fluoroethyl)-L-tyrosine (FET) PET for the differentiation between local...